載入...
EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
BACKGROUND: It has been confirmed that epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) presented better efficacy than brain radiotherapy (brain RT) in the treatment of brain metastasis (BM) in EGFR mutated NSCLC patients. However, whether the combination of EGFR-TKIs and brai...
Na minha lista:
| 發表在: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626863/ https://ncbi.nlm.nih.gov/pubmed/31367540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.12 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|